LeMaitre Q1 2026 Financial Results
LeMaitre Vascular, Inc. reported a strong Q1 2026 with a 36% growth in Artegraft sales, record performances in grafts and related products, and an increased gross margin of 72.7%. The company announced a quarterly dividend of $0.25 per share and provided guidance for 12% sales growth and 26% adjusted EPS growth for the full year. The management highlighted successful geographic expansions and increased pricing as key factors in their performance.
BURLINGTON, Mass., May 05, 2026 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q1 2026 results, announced a quarterly dividend of $0.25/share, and provided guidance.